RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sorrento Therapeutics Stock

Sorrento Therapeutics Equity 2025

Sorrento Therapeutics Equity

-18.6 M USD

Ticker

SRNE

ISIN

US83587F2020

WKN

A1W8DY

In 2025, Sorrento Therapeutics's equity was -18.6 M USD, a 0% increase from the 0 USD equity in the previous year.

Sorrento Therapeutics Aktienanalyse

What does Sorrento Therapeutics do?

Sorrento Therapeutics is a biotechnology company based in San Diego, California. It was founded in 2006 by Dr. Henry Ji and specializes in the research and development of biopharmaceuticals, particularly in the field of oncology. Sorrento Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Sorrento Therapeutics's Equity

Sorrento Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sorrento Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sorrento Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sorrento Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sorrento Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sorrento Therapeutics stock

What is the equity of Sorrento Therapeutics this year?

Sorrento Therapeutics has equity of -18.6 M USD this year.

What was the equity of Sorrento Therapeutics compared to the previous year?

The equity of Sorrento Therapeutics has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Sorrento Therapeutics?

A high equity is advantageous for investors of Sorrento Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Sorrento Therapeutics?

A low equity can be a risk for investors of Sorrento Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Sorrento Therapeutics affect the company?

An increase in equity of Sorrento Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Sorrento Therapeutics affect the company?

A reduction in equity of Sorrento Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Sorrento Therapeutics?

Some factors that can affect the equity of Sorrento Therapeutics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Sorrento Therapeutics so important for investors?

The equity of Sorrento Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Sorrento Therapeutics take to change the equity?

To change equity, Sorrento Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Sorrento Therapeutics pay?

Over the past 12 months, Sorrento Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sorrento Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Sorrento Therapeutics?

The current dividend yield of Sorrento Therapeutics is .

When does Sorrento Therapeutics pay dividends?

Sorrento Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sorrento Therapeutics?

Sorrento Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Sorrento Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sorrento Therapeutics located?

Sorrento Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sorrento Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sorrento Therapeutics from 9/27/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2025.

When did Sorrento Therapeutics pay the last dividend?

The last dividend was paid out on 9/27/2025.

What was the dividend of Sorrento Therapeutics in the year 2024?

In the year 2024, Sorrento Therapeutics distributed 0 USD as dividends.

In which currency does Sorrento Therapeutics pay out the dividend?

The dividends of Sorrento Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Sorrento Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Sorrento Therapeutics

Our stock analysis for Sorrento Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sorrento Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.